Study Stopped
Funds for study ended September 30, 2008.
Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository)
Gen/Phen
Comprehensive Sickle Cell Centers (CSCC) Collaborative Genotype-Phenotype Database and Sample Repository
2 other identifiers
observational
3,640
1 country
13
Brief Summary
Sickle cell disease (SCD), also known as sickle cell anemia, is an inherited blood disease that can cause intense pain episodes. The purpose of this study is to collect, test, and archive blood and DNA samples from children and adults with SCD to study the role that genes play in SCD. Blood and DNA samples will be stored for use in future SCD studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2007
13 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2007
CompletedFirst Submitted
Initial submission to the registry
September 10, 2007
CompletedFirst Posted
Study publicly available on registry
September 12, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2008
CompletedJuly 12, 2016
November 1, 2008
1.1 years
September 10, 2007
July 11, 2016
Conditions
Keywords
Eligibility Criteria
All adult and pediatric patients who are enrolled in the C-Data project are eligible for this study. (C-Data eligibility: All adult and pediatric patients who have been seen within the last 24 months in the hospital or clinical setting and are expected to return episodically or regularly for care at 1 of the CSCC are eligible for inclusion in the C-Data project.)
You may qualify if:
- Participating in the C-Data project
You may not qualify if:
- Unable to undergo blood collection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (13)
Children's Hospital Oakland
Oakland, California, 94609, United States
University of California, San Francisco
San Francisco, California, 94134, United States
Brigham & Women's Hospital
Boston, Massachusetts, 02115, United States
Children's Hospital of Boston
Boston, Massachusetts, 02115, United States
Boston Medical Center
Boston, Massachusetts, 02118, United States
Montefiore Medical Center
The Bronx, New York, 10463, United States
University of North Carolina-Chapel Hill
Chapel Hill, North Carolina, 27599, United States
Cincinnati Children's Hospital
Cincinnati, Ohio, 45229, United States
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19104, United States
St. Christopher's Hospital for Children
Philadelphia, Pennsylvania, 19134, United States
Children's Medical Hospital of Dallas
Dallas, Texas, 75235, United States
University of Texas Southwestern & Parkland
Dallas, Texas, 75235, United States
University of Texas at Galveston
Galveston, Texas, 77555, United States
Biospecimen
Plasma, Lymphocytes, Whole blood, RBC hemolysate, DNA
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carolyn Hoppe, MD
UCSF Benioff Children's Hospital Oakland
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
Study Record Dates
First Submitted
September 10, 2007
First Posted
September 12, 2007
Study Start
August 1, 2007
Primary Completion
September 1, 2008
Study Completion
September 1, 2008
Last Updated
July 12, 2016
Record last verified: 2008-11